[Graft-versus-host disease: friend or foe?].
Kanda
Yoshinobu
Y
D000208:Acute Disease; D002469:Cell Separation; D016572:Cyclosporine / Q000008:administration & dosage; D018572:Disease-Free Survival; D006086:Graft vs Host Disease / Q000517:prevention & control; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D013601:T-Lymphocytes; D016559:Tacrolimus / Q000008:administration & dosage; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus; D008727:Methotrexate